All In MedTech

Device Trial Radar · NCT07147881

Prospective Real-World Evidence Study of the IpsiHand® System in Adult Stroke Survivors

Last checked: Nov 20, 2026Latest source record: Aug 29, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

Sep 1, 2025

Primary completion

Dec 1, 2027

Study completion Jan 1, 2028

Sponsor

Lead sponsor
Neurolutions, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Aug 29, 2025

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study focuses on monitoring real-world customers who have been prescribed the IpsiHand® as part of their rehabilitation post-stroke. This study aims to evaluate their progress over time, assessing motor recovery, functional independence in activities of daily living (ADLs), caregiver burden, and health economic outcomes.

Conditions

  • Stroke
  • Hemiparesis After Stroke
  • Brain Computer Interface

Interventions

  • IpsiHandDevice

    IpsiHand is a therapeutic device that uses a brain-computer interface system which detects neural signals associated with motor intent and translates them into assisted hand movements in individuals with upper extremity impairment following a stroke.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Fugl-Meyer - Upper Extremity (FM-UE) , Manual Long FormTime frame: Baseline visit and at 4-week, 8-week, 12-week, 16-week, 20-week, 24-week, 28-week, 32-week, 36-week, 12-months, and 24 months of IpsiHand® device use, or until completion of IpsiHand® device use if occurring prior to 24 months.

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.